Your search returned 28 studies. (Get alerts for new studies):
- A Phase 2 Study to Evaluate the Efficacy and Safety of AB0024 in Adults With Myelofibrosis
Conditions: Myelofibrosis
2 Locations available
- Clinical and Basic Investigations Into Erdheim Chester Disease
Conditions: Myelofibrosis - Gaucher Disease - Pulmonary Fibrosis - Hermansky-Pudlak Syndrome (HPS) - Cancer
1 Location available
- Pomalidomide for Myelofibrosis Patients
Conditions: Polycythemia Vera - Thrombocythemia
1 Location available
- Study of Reduced Intensity Allogeneic Peripheral Blood Stem Cell Transplantation (PBSCT) to Treat Hematologic Malignancies and Hematopoietic Failure S
Conditions: Hematologic Neoplasms - Multiple Myeloma - Anemia, Aplastic - Hemoglobinuria, Paroxysmal - Myelofibrosis
1 Location available
- Fludarabine, Cyclophosphamide, and Total-Body Irradiation in Treating Patients Who Are Undergoing an Umbilical Cord Blood Transplant for Hematologic C
Conditions: Acute Myeloid Leukemia - Acute Lymphocytic Leukemia - Chronic Myelogenous Leukemia - Myelofibrosis - MDS - Refractory Anemia - Chronic Lymphocytic Leukemia - Prolymphocytic Leukemia - Multiple Myeloma - Non-Hodgkin's Lymphoma - Leukemia - Lymphoma - Multi
1 Location available
- Familial Myeloproliferative Disorders
Conditions: Polycythemia Vera - Essential Thrombocythemia - Idiopathic Myelofibrosis
5 Locations available
- Ruxolitinib (INCB018424) in Subjects With Primary Myelofibrosis, Post Essential Thrombocythemia-myelofibrosis and Post Polycythemia Vera-myelofibrosis
Conditions: Primary Myelofibrosis - Post Essential Thrombocythemia-myelofibrosis - Post Polycythemia Vera-myelofibrosis
34 Locations available
- Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Conditions: Hematopoietic Neoplasm
6 Locations available
- Genetic Analysis of Gray Platelet Syndrome
Conditions: Genetic Linkage - Myelofibrosis
1 Location available
- Research Tissue Bank
Conditions: Myelofibrosis - Idiopathic Myelofibrosis - Essential Thrombocythemia - Polycythemia Vera
9 Locations available
- Polycythemia Vera, Myelofibrosis and Essential Thrombocythemia: Identification of PV, MF & ET Genes
Conditions: Polycythemia Vera - Essential Thrombocythemia - Myelofibrosis
1 Location available
- Ruxolitinib and Lenalidomide for Patients With Myelofibrosis
Conditions: Myeloproliferative Diseases
1 Location available
- Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease
Conditions: Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Precancerous Condition - Secondary Myelofibrosis
1 Location available
- Study of Oral Arsenic Trioxide With or Without Ascorbic Acid in Adults With Myelofibrosis
Conditions: Primary Myelofibrosis
1 Location available
- Phase-3 Double-Blind, Placebo-Controlled Study of Pomalidomide in Persons With Myeloproliferative-Neoplasm-Associated Myelofibrosis and RBC-Transfusio
Conditions: Primary Myelofibrosis
2 Locations available
- Bioequivalence Trial of Luitpold Azacitidine Versus Vidaza® in Patients With Myelodysplastic Syndrome, Myelofibrosis, Chronic Myeloid Leukemia or Chro
Conditions: Myelodysplastic Syndrome - Myelofibrosis - Chronic Myeloid Leukemia - Chronic Lymphocytic Leukemia
1 Location available
- Safety and Tolerability Study of Oral NS-018 in Patients With Primary Myelofibrosis (MF), Post-polycythemia Vera MF or Post-essential Thrombocythemia
Conditions: Primary Myelofibrosis - Post-Polycythemic Vera Myelofibrosis - Post-Essential Thrombocythemia Myelofibrosis
2 Locations available
- Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease
Conditions: Chronic Myeloproliferative Disorders - Graft Versus Host Disease - Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms - Secondary Myelofibrosis - Small Intestine Cance
1 Location available
- CEP-701 (Lestaurtinib) in Myelofibrosis
Conditions: Myelofibrosis - Essential Thrombocythemia - Polycythemia Vera
7 Locations available
- A Study in Myeloproliferative Disorders
Conditions: Myeloproliferative Disorders - Thrombocythemia, Essential - Polycythemia Vera - Primary Myelofibrosis
3 Locations available
- TXA127 in Enhancement of Engraftment in Adult Double Cord Blood Transplantation
Conditions: Double Cord Blood Transplant - Acute Myelogenous Leukemia - Myelodysplastic Syndrome - Myelofibrosis - Acute Lymphoblastic Leukemia - Chronic Myelocytic Leukemia - Non Hodgkins Lymphoma - Hodgkins Lymphoma - Chronic Lymphocytic Leukemia
1 Location available
- Study of the JAK Inhibitor Ruxolitinib Administered Orally to Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera-Myelofibrosis (PPV-MF)
Conditions: Myelofibrosis
3 Locations available
- A Phase 2 Study With IPI-926 in Patients With Myelofibrosis
Conditions: Primary Myelofibrosis - Fibrosis, Bone Marrow
3 Locations available
- Safety Study Evaluating Twice-Daily Administration of CYT387 in Primary Myelofibrosis or Post-Polycythemia Vera or Post-Essential Thrombocythemia Myel
Conditions: Primary Myelofibrosis - Post-Polycythemia Vera - Post-Essential Thrombocythemia Myelofibrosis
3 Locations available
- Sibling Donor Peripheral Stem Cell Transplant or Sibling Donor Bone Marrow Transplant in Treating Patients With Hematologic Cancers or Other Diseases
Conditions: Chronic Myeloproliferative Disorders - Graft Versus Host Disease - Leukemia - Lymphoma - Myelodysplastic Syndromes - Secondary Myelofibrosis
1 Location available
- Correlative Biomarker Study in Patients With Myeloproliferative Disorders
Conditions: Myeloproliferative Disease - Myelofibrosis - Idiopathic Myelofibrosis - Essential Thrombocythemia - Polycythemia Vera
6 Locations available
- Study of Hypoxia-Activated Prodrug TH-302 to Treat Advanced Leukemias
Conditions: Acute Myelogenous Leukemia - Acute Lymphoblastic Leukemia - Chronic Myelogenous Leukemia - High-risk Myelodysplastic Syndrome - Chronic Lymphocytic Leukemia - Advanced Myelofibrosis
1 Location available
- Alternative Dosing Strategy of Ruxolitinib in Patients With Myelofibrosis
Conditions: Primary Myelofibrosis - Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase
15 Locations available
|